Clinical trial Recruiting at 1 site Interventional Ages 18 to 40 Women only

Virtual Reality Storytelling to Support First-Time Moms During Pregnancy

Official title: Evaluation of the Effects of Digital Storytelling Applied to Primiparous Pregnant Women With Virtual Reality Glasses on Prenatal Attachment, Fear of Childbirth, Perception of Childbirth Self-Efficacy, and Non-Stress Test Results

Run by Bozok University · NCT07167030 · Data updated 2026-11-12

This trial tests whether a digital storytelling program delivered through virtual reality can help first-time pregnant women feel more connected to their baby, feel less fear about childbirth, and feel more confident about labor.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment112 (estimated)
SponsorBozok University
Academic / other
Locations1 site (Yozgat, Yozgat)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedNovember 30, 2026
Study endsDecember 30, 2026
Registry record updatedOctober 16, 2026
Trial IDNCT07167030 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Primiparous women aged 18-40 at approximately 28 weeks gestation with singleton pregnancies, able to understand Turkish, and without serious vision/balance issues or high-risk pregnancy complications.

Probably not a fit

Women with high-risk pregnancies, fetal anomalies, psychiatric diagnoses, or any condition preventing VR use may derive no benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial evaluates a digital storytelling program delivered via virtual reality glasses for primiparous pregnant women around 28 weeks gestation. Participants are assigned to either the VR storytelling intervention plus standard care or standard care alone. The study measures prenatal attachment, fear of childbirth, perceived childbirth self-efficacy, and non-stress test results. The aim is to determine if the holistic audiovisual approach improves multidimensional prenatal experiences compared with standard care.

Why it matters

Potential benefit: If successful, the intervention could enhance prenatal attachment, reduce childbirth fear, and strengthen self-efficacy, potentially improving pregnancy experience and birth outcomes.

How similar studies have gone: Previous research on VR-based prenatal education has shown promise for reducing anxiety; this study applies a holistic digital storytelling approach to multidimensional outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Primiparous women in their 28th week of pregnancy
* Between the ages of 18 and 40
* Experiencing a singleton pregnancy
* Applied to the Yozgat City Hospital Gynecology and Obstetrics Clinic and agreed to participate in the study
* Have a primary school education and can understand Turkish
* Have no serious vision or balance problems that would prevent the use of VR glasses
* Have not experienced any risky pregnancy problems (premature membrane rupture, preeclampsia, gestational diabetes, etc.)
* Have no identified fetal anomalies
* Have no psychiatric diagnosis

Exclusion Criteria:

* Pregnant women who cannot obtain a work permit and who do not agree to participate in the study will not be included in the study.

Where it's running

  • Yozgat Şehir Hastanesi
    Yozgat, Yozgat, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.